Use of home oxygen is associated with reduced physical function in patients with either COPD or idiopathic pulmonary fibrosis.
Routine use of supplemental oxygen does not reduce one-year all-cause mortality versus ambient air
Researchers find oxygen therapy does not improve quality of life, forestall hospitalization, lengthen lives
ID Week 2022
Current evidence indicates that a 6mg dose of dexamethasone daily is effective for improving COVID-19 outcomes among patients receiving supplemental oxygen.
Kineret is an interleukin-1 receptor antagonist.
Investigators developed and validated a machine learning tool providing an early indication of disease progression in community-acquired pneumonia.
The approval was based on data from the phase 3 ACTT-2 and COV-BARRIER studies.
Investigators report findings from a secondary analysis of the DARE-19 trial, which compared dapagliflozin with placebo in patients hospitalized with COVID-19.